To avoid the appearance of    Price announced last week that he would divest from 43 companies    including Zimmer Biomet    within 90 days of Senate confirmation. He said he will "not participate personally and substantially in any particular matter" on an issue that could affect any of those companies if he has not yet fully divested from them.   But as a congressman, Price did not appear to adhere to such strict limits, including with Zimmer Biomet. As one of the prominent GOP voices on health care, Price sat on an influential Ways and Means subcommittee that directly oversees health care policy.   